Relationship of resistin levels with endometrial cancer risk

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00051781" target="_blank" >RIV/00216224:14110/11:00051781 - isvavai.cz</a>
Alternative codes found
RIV/65269705:_____/11:#0001600
Result on the web
<a href="http://dx.doi.org/10.4149/neo_2011_02_124" target="_blank" >http://dx.doi.org/10.4149/neo_2011_02_124</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4149/neo_2011_02_124" target="_blank" >10.4149/neo_2011_02_124</a>

Result language
angličtina
Original language name
Relationship of resistin levels with endometrial cancer risk
Original language description
Cancer of endometrium (CAE) is the most common gynecologic malignancy in industrialized nations. Increased resistin levels, an adipocytokine produced by adipose tissue and macrophages, have been considered as a risk factor in gastric, colon and breast cancer, recently. No studies associating resistin levels with endometrial cancer have been done so far. The purpose of this case-control study was to determine the relationship between serum circulating resistin levels and resistin gene -420C>G (rs3219175) variant in endometrial cancer patients. 37 Caucasian female patients and 39 healthy controls were enrolled in this study. Difference in resistin levels between age and BMI matched patients group (mean 24.2 ng/ml) and control subjects (mean 10.1 ng/ml) were statistically significant (p G (rs3219175) within resistin gene and no significant association between resistin levels and investigated polymorphism was found.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)